Education
About Us
Working with TipRanks
Follow Us
Biofrontera AG (GB:0DOL)
LSE:0DOL
| Dec 23 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 16.63M | $ 26.40M | $ 26.70M | $ 16.66M | $ 10.31M |
| Operating Income | $ -22.68M | $ -11.85M | $ -23.87M | $ -18.48M | $ -13.93M |
| EBITDA | $ -18.45M | $ 3.90M | $ -5.92M | $ -16.73M | $ -14.09M |
| Net Income | $ -20.13M | $ -4.29M | $ -14.12M | $ -8.88M | $ -15.25M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 27.93M | $ 56.39M | $ 58.36M | $ 39.13M | $ 19.85M |
| Total Debt | $ 5.40M | $ 1.14M | $ 1.21M | $ 13.63M | $ 12.53M |
| Net Debt | $ 4.06M | $ -15.41M | $ -9.91M | $ -6.62M | $ 872.00K |
| Total Liabilities | $ 23.14M | $ 96.76M | $ 93.26M | $ 22.78M | $ 16.47M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -24.91M | $ -2.85M | $ -32.89M | $ -13.95M | $ -13.52M |
| Operating Cash Flow | $ -24.90M | $ -2.85M | $ -32.89M | $ -13.43M | $ -13.12M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Biofrontera Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.